Search Results 191-200 of 17319 for Proto-oncogene
Dr. Kaufmann and his team in the Anticancer Drug Action Lab at Mayo Clinic are studying cellular responses to DNA damage induced by topoisomerase poisons.
The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.
Stock Footage. About the News Network · Newsbureau@mayo.edu · News Releases · Cancer · Cardiovascular · Gastroenterology · Neurosciences · Transplant.
This week's podcast episode of Tomorrow's Cure explores how DNA could be used to detect blood cancers before they ever develop.
Mayo Clinic's Engineering & Therapeutics in Gastrointestinal Disease Lab is developing new ways to deliver gene therapy into organs through endoscopic ...
The overall hypothesis is that the early detection of genetic variants leads to early interventions in cancer development. This will lead to lower rates of ...
Biomarkers from circulating cell-free tumor DNA in peripheral blood will identify patients with metastatic prostate cancer diagnosed with C11 choline PET/CT who ...
Oncogene. 2013; doi:10.1038/onc.2012.628. Ingle JN, et al. Estrogens and their precursors in postmenopausal women with early breast cancer receiving ...
The study will evaluate avatrombopag in the treatment of thrombocytopenia associated with liver disease prior to an elective procedure to reduce the need for ...
Mayo Clinic researchers discover the immune system's 'fountain of youth'. Researchers found a link between "immune youth," a new term coined by Mayo ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift doubles in impact to help more patients.